Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
About 80 percent of breast cancers express the estrogen receptor (ER). In ER-positive tumors, estrogen is the main driver...
From a joyous opening performance from the Preservation Hall All-Stars to a closing plenary that highlighted the full spectrum...
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are...
For June, the editors of the AACR’s 10 journals chose to spotlight a characterization of an investigational KRAS inhibitor,...
Gregory J. Aune, MD, PhD, is a renowned pediatric oncologist with a powerful story. At age 16, he was...
June 2022 marked the 10th Annual Cancer Immunotherapy Month spearheaded by the Cancer Research Institute. Immunotherapy is an umbrella...
Although childhood cancer is rare, it represents the leading cause of death by disease in children in developed countries....
As we celebrate National Cancer Survivor Month, we are aware how the term survivor can take on many meanings...
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
Karriem Watson is a public health expert serving as chief engagement officer of the National Institutes of Health’s All...